Squarepoint
SGYP

Squarepoint’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Squarepoint’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-58,464
Closed -$99K – 2422
2018
Q3 		$99K Buy
58,464
+17,413
+42% +$31.2K ﹤0.01% 1888
2018
Q2 		$71K Buy
+41,051
New +$71K ﹤0.01% 1672
2018
Q1 		– Sell
-181,127
Closed -$404K – 2415
2017
Q4 		$404K Buy
+181,127
New +$450K 0.01% 1325
2017
Q1 		– Sell
-122,788
Closed -$748K – 2118
2016
Q4 		$748K Buy
122,788
+103,388
+533% +$540K 0.03% 618
2016
Q3 		$107K Buy
+19,400
New +$90.8K 0.01% 948
2016
Q1 		– Sell
-66,500
Closed -$377K – 1588
2015
Q4 		$377K Buy
+66,500
New +$405K 0.04% 692

Other funds holding SGYP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JG
Jefferies Group New York $3.42B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return